iodine has been researched along with Adenocarcinoma Of Kidney in 11 studies
Iodine: A nonmetallic element of the halogen group that is represented by the atomic symbol I, atomic number 53, and atomic weight of 126.90. It is a nutritionally essential element, especially important in thyroid hormone synthesis. In solution, it has anti-infective properties and is used topically.
diiodine : Molecule comprising two covalently bonded iodine atoms with overall zero charge..
| Excerpt | Relevance | Reference |
|---|---|---|
| "We aimed to evaluate whether rapid kV-switching dual energy CT (rsDECT) can discriminate between papillary renal cell carcinoma (RCC) and benign proteinaceous cysts (BPCs) based on iodine and water content." | 7.96 | Discrimination of papillary renal cell carcinoma from benign proteinaceous cyst based on iodine and water content on rapid kV-switching dual-energy CT. ( Çamlıdağ, İ; Danacı, M; Kalkan, C; Nural, MS, 2020) |
| "We aimed to evaluate whether rapid kV-switching dual energy CT (rsDECT) can discriminate between papillary renal cell carcinoma (RCC) and benign proteinaceous cysts (BPCs) based on iodine and water content." | 3.96 | Discrimination of papillary renal cell carcinoma from benign proteinaceous cyst based on iodine and water content on rapid kV-switching dual-energy CT. ( Çamlıdağ, İ; Danacı, M; Kalkan, C; Nural, MS, 2020) |
| "Dual energy CT-based quantification of iodine content of mRCC metastases allows for significantly more sensitive and reproducible detection of antiangiogenic treatment effects." | 3.85 | Dual energy CT allows for improved characterization of response to antiangiogenic treatment in patients with metastatic renal cell cancer. ( Casuscelli, J; Graser, A; Hellbach, K; Hummel, N; Ingrisch, M; Karpitschka, M; Schlemmer, M; Sommer, W; Staehler, M; Sterzik, A, 2017) |
| "Iodine concentration was higher in cc-RCC (6." | 1.56 | Characterization of clear cell renal cell carcinoma and other renal tumors: evaluation of dual-energy CT using material-specific iodine and fat imaging. ( Chatelain, R; Flood, TA; Krishna, S; McInnes, MD; Schieda, N; Udare, A; Walker, D, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (27.27) | 24.3611 |
| 2020's | 8 (72.73) | 2.80 |
| Authors | Studies |
|---|---|
| Drljevic-Nielsen, A | 1 |
| Mains, JR | 1 |
| Thorup, K | 1 |
| Andersen, MB | 1 |
| Rasmussen, F | 1 |
| Donskov, F | 1 |
| Zhang, X | 1 |
| Zhang, G | 1 |
| Xu, L | 1 |
| Bai, X | 1 |
| Zhang, J | 1 |
| Chen, L | 1 |
| Lu, X | 1 |
| Yu, S | 1 |
| Jin, Z | 1 |
| Sun, H | 1 |
| Li, Z | 1 |
| Wang, N | 1 |
| Bing, X | 1 |
| Li, Y | 1 |
| Yao, J | 1 |
| Li, R | 1 |
| Ouyang, A | 1 |
| Udare, A | 1 |
| Walker, D | 1 |
| Krishna, S | 1 |
| Chatelain, R | 1 |
| McInnes, MD | 1 |
| Flood, TA | 1 |
| Schieda, N | 1 |
| Çamlıdağ, İ | 1 |
| Nural, MS | 1 |
| Kalkan, C | 1 |
| Danacı, M | 1 |
| Manoharan, D | 1 |
| Netaji, A | 1 |
| Diwan, K | 1 |
| Sharma, S | 1 |
| Zhang, B | 1 |
| Wu, Q | 1 |
| Qiu, X | 1 |
| Ding, X | 1 |
| Wang, J | 1 |
| Li, J | 1 |
| Sun, P | 1 |
| Hu, X | 1 |
| Sun, J | 1 |
| Zhang, XY | 1 |
| Li, XT | 1 |
| Li, YL | 1 |
| Wang, ZL | 1 |
| Marcon, J | 1 |
| Graser, A | 2 |
| Horst, D | 1 |
| Casuscelli, J | 2 |
| Spek, A | 1 |
| Stief, CG | 1 |
| Reiser, MF | 1 |
| Rübenthaler, J | 1 |
| Buchner, A | 1 |
| Staehler, M | 2 |
| Hellbach, K | 1 |
| Sterzik, A | 1 |
| Sommer, W | 1 |
| Karpitschka, M | 1 |
| Hummel, N | 1 |
| Ingrisch, M | 1 |
| Schlemmer, M | 1 |
| Lankheet, NA | 1 |
| Blank, CU | 1 |
| Mallo, H | 1 |
| Adriaansz, S | 1 |
| Rosing, H | 1 |
| Schellens, JH | 1 |
| Huitema, AD | 1 |
| Beijnen, JH | 1 |
11 other studies available for iodine and Adenocarcinoma Of Kidney
| Article | Year |
|---|---|
Early reduction in spectral dual-layer detector CT parameters as favorable imaging biomarkers in patients with metastatic renal cell carcinoma.
Topics: Biomarkers; Carcinoma, Renal Cell; Humans; Iodine; Kidney Neoplasms; Retrospective Studies; Tomograp | 2022 |
Prediction of World Health Organization /International Society of Urological Pathology (WHO/ISUP) Pathological Grading of Clear Cell Renal Cell Carcinoma by Dual-Layer Spectral CT.
Topics: Carcinoma, Renal Cell; Humans; Iodine; Kidney Neoplasms; Neoplasm Grading; Retrospective Studies; To | 2023 |
The value of a dual-energy CT Iodine map radiomics model for the prediction of collagen fiber content in the ccRCC tumor microenvironment.
Topics: Carcinoma, Renal Cell; Collagen; Humans; Iodine; Kidney Neoplasms; Retrospective Studies; Tumor Micr | 2023 |
Characterization of clear cell renal cell carcinoma and other renal tumors: evaluation of dual-energy CT using material-specific iodine and fat imaging.
Topics: Adipose Tissue; Aged; Carcinoma, Renal Cell; Contrast Media; Diagnosis, Differential; Female; Humans | 2020 |
Discrimination of papillary renal cell carcinoma from benign proteinaceous cyst based on iodine and water content on rapid kV-switching dual-energy CT.
Topics: Carcinoma, Renal Cell; Contrast Media; Cysts; Diagnosis, Differential; Female; Humans; Iodine; Kidne | 2020 |
Normalized Dual-Energy Iodine Ratio Best Differentiates Renal Cell Carcinoma Subtypes Among Quantitative Imaging Biomarkers From Perfusion CT and Dual-Energy CT.
Topics: Adult; Aged; Biomarkers; Carcinoma, Renal Cell; Contrast Media; Diagnosis, Differential; Female; Hum | 2020 |
Effect of spectral CT on tumor microvascular angiogenesis in renal cell carcinoma.
Topics: Adult; Aged; Biomarkers; Carcinoma, Renal Cell; Contrast Media; Disease Management; Female; Humans; | 2021 |
Use of Iodine Concentration in the Lipid-Poor Portion of the Renal Mass for Differentiation of Angiomyolipoma from Renal Cell Carcinoma.
Topics: Adult; Aged; Angiomyolipoma; Carcinoma, Renal Cell; Contrast Media; Diagnosis, Differential; Female; | 2019 |
Papillary vs clear cell renal cell carcinoma. Differentiation and grading by iodine concentration using DECT-correlation with microvascular density.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Papillary; Carcinoma, Renal Cell; Cell Transformation, Ne | 2020 |
Dual energy CT allows for improved characterization of response to antiangiogenic treatment in patients with metastatic renal cell cancer.
Topics: Aged; Angiogenesis Inhibitors; Carcinoma, Renal Cell; Contrast Media; Female; Humans; Indoles; Iodin | 2017 |
Determination of sunitinib and its active metabolite N-desethylsunitinib in sweat of a patient.
Topics: Administration, Oral; Aged; Antineoplastic Agents; Biotransformation; Calibration; Carcinoma, Renal | 2011 |